Current through Register Vol. 49, No. 13, September 23, 2024
Subpart
1.
Commissioner's authority.
The commissioner must approve any medical cannabis laboratory
that tests medical cannabis for a registered medical cannabis manufacturer
under Minnesota Statutes, section
152.25, subdivision 1, paragraph
(d). A medical cannabis laboratory may seek approval to use specific procedures
to test the allowable product types and analytes according to parts 4770.1900
to 4770.2400, which specify the commissioner's requirements authorized by
Minnesota Statutes, section
152.29, subdivision 1, paragraph
(b).
Subp. 2.
Eligibility.
The commissioner may only approve a medical cannabis
laboratory that tests under a contract with a medical cannabis manufacturer
that can demonstrate its eligibility under this subpart. The laboratory
must:
A. operate using proper
laboratory equipment under a quality assurance system and test product types
for analytes listed in the commissioner's list in subpart 3;
B. test medical cannabis delivered in the
product types specified in subpart 4;
C. test accurately for the following
elements:
(1) content, by testing for
analytes for a cannabinoid profile;
(2) contamination, by testing for analytes
for:
(a) metals;
(b) pesticide residues and plant growth
regulators;
(c) microbiological
contaminants and mycotoxins; and
(d) residual solvents; and
(3) consistency of medical
cannabis by testing for stability.
Subp. 3.
Commissioner list of approved
cannabis labs.
A. The commissioner must
publish a list of approved cannabis laboratories in the State Register and on
the department's medical cannabis program Web site at least annually.
B. The commissioner must provide the
following information for each approved laboratory:
(1) its scope of approval;
(2) name, telephone number, and e-mail
address of primary laboratory contact; and
(3) physical and mailing address of
laboratory.
Subp.
4.
Commissioner's approved medical cannabis product
types.
The commissioner's approved product types include:
A. liquid, including in oil form;
B. pill;
C. vaporized delivery method using liquid or
oil;
D. dried raw cannabis
intended to be used or consumed by combustion; and
E. any other method approved by the commissioner under
Minnesota Statutes, section
152.27, subdivision 2, paragraph
(b).
Subp. 5.
Commissioner's analyte list.
A.
The commissioner must maintain a list of analytes that laboratories must be
able to test for. The analyte categories include:
(1) cannabinoid profile;
(2) metals;
(3) pesticide residues and plant growth
regulators;
(4) microbiological
contaminants and mycotoxins; and
(5) residual solvents.
B. The commissioner must publish the analyte
list in the State Register and on the department's medical cannabis program Web
site.
C. The commissioner must
review the analyte list and publish a notice of any analyte updates in the
State Register and on the department's medical cannabis program Web site at
least every six months.
